Aim: This study aimed to prepare binary ethylenimine (BEI)-inactivated virulent Newcastle disease virus (NDV) vaccine and to examine their ability to induce a protective antibody response in commercial chickens.

Materials and Methods: A virulent NDV field isolate Gianyar-1/AK/2014 was propagated in chicken-embryonated eggs and was then inactivated with BEI at a concentration of 4 mM. Three groups of chickens with low-level (2 log₂ hemagglutination inhibition [HI] units) maternally derived antibodies against NDV were then immunized with the BEI-inactivated vaccine. A commercial live vaccine (LaSota strain) was used as positive control, and phosphate-buffered saline (PBS) was used as negative control. A challenge experiment with a virulent NDV of Tabanan-1/ARP/2017 was performed at 3 weeks post-vaccination.

Results: At 2 weeks post-immunization, the mean titers of antibodies against NDV in serum samples of chickens immunized with 0.2 mL of BEI-inactivated NDV (Group I), with live commercial NDV vaccine (Group II) and with PBS (Group III) were 3±0.94 log₂ HI units, 4.9±0.99 log₂ HI unit, and 0.0±0.0 HI units, respectively. At week 3 post-immunization, the mean titers of the antibodies for the three groups were 5±1.09 log₂ HI units, 6.9±0.32 log₂ HI units, and 0.00 HI units, respectively. The antibody titer induced by inactivated NDV Gianyar-1/AK/2014 isolates examined at 2 and 3 weeks post-vaccination was still at a significantly (p<0.01) lower level as compared to those induced by commercial life vaccine. However, the challenge test with virulent NDV of Tabanan 1/ARP/2017 isolates showed that all immunized chickens (Group I and II) survived without exhibiting any clinical sign post-challenge with the protection rates of 100%, whereas all chickens injected with PBS (Group III) died with clinical signs of ND.

Conclusion: This finding shows that the BEI-inactivated vaccines prepared using virulent NDV of Gianyar-1/AK/2014 strain was able to induce protective antibody response in chickens but still at a lower level than those induce by commercial live NDV vaccine.

Keywords: genotype VII, inactivated vaccine, live vaccine, Newcastle disease virus.

1. Courtney, S.C., Susta, L., Gomez, D., Hines, N.L., Pedersen, J.C., Brown, C.C. and Afonso, C.L. (2013) Highly divergent virulent isolates of Newcastle disease virus from the Dominican Republic are members of a new genotype that may have evolved unnoticed for over 2 decades. J. Clin. Microbiol., 51(2): 508-517. [Crossref] [PubMed] [PMC]

2. Adi, A.A.A., Astawa, N.M., Putra, K.S.A., Hayashi, Y. and Matsumoto, Y. (2010) Isolation and characterization of pathogenic Newcastle disease virus from natural case in Indonesia. J. Vet. Med. Sci., 72(3): 313-319. [Crossref]

3. Xiao, S., Nayak, B., Samuel, A., Paldurai, A., Kanabagattebasavarajappa, M., Prajitno, T.Y., Bharoto, E.E., Collins, P.L. and Samal, S.K. (2012) Generation by reverse genetics of an effective, stable, live-attenuated Newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain. PLoS One, 7(12): e52751. [Crossref] [PubMed] [PMC]

4. Harmayanti, N.L.P., Hartawan, R., Hewajuli, D.A. and Indriani, R. (2014) Phylogenetic analysis of genotype VII of Newcastle disease virus in Indonesia. Afr. J. Microbiol. Res., 8(13): 1368-1374. [Crossref]

5. Putra, I.G.A., Adi, A.A.A. and Astawa, N.M. (2016) Variasi genetik gen penyandi protein fusi dari Avian paramyxovirus Tipe I di Bali. J. Vet., 17(2): 211-217. [Crossref]

6. Putri, D.D., Handharyani, E., Soejoedono, R.D., Setiyono, A., Mayasari, N.I. and Poetri, O.N. (2018) Genotype characterization of Newcastle disease virus isolated from commercial chicken flocks in West Java, Indonesia. Pak. Vet. J., 38(2): 184-188. [Crossref]

7. Cornax, I., Miller, P.J. and Afonso, C.L. (2012) Characterization of live LaSota vaccine strain induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype. Avian Dis., 56(3): 464-470. [Crossref] [PubMed]

8. O.I.E World Health Organization. (2012) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Mammals, Birds and Bees. Newcastle Disease (Infection with Newcastle Disease Virus). Ch. 2.3.14. Office International des Epizooties, Paris. p555-574. https://www.oie.int/doc/ged/D12008.PDF. Last accessed on 07-12-2018.

9. Kapczynski, D.R., Afonso, C.L. and Miller, P.J. (2013) Immune responses of poultry to Newcastle disease virus. Dev. Comp. Immunol., 41(3): 447-453. [Crossref] [PubMed]

10. Koppad, S., Raj, G.D., Gopinath, V.P., Kirubaharan, J.J., Thangavelu, A. and Thiagarajan, V. (2011) Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell-mediated immune responses in chickens. Res. Vet. Sci., 91(3): 384-90. [Crossref] [PubMed]

11. Dimitrov, K.M., Afonso, C.L., Yu, Q. and Miller, P.J. (2017) Newcastle disease vaccines-a solved problem or a continuous challenge? Vet. Microbiol., 206(7): 126-136. [Crossref] [PubMed]

12. Bonnafous, P., Nicolai, M.C., Taveau, J.C., Chevalier, M., Barriere, F., Medina, J., Bihan, O.L., Adam, O., Ronzo, F. and Lambert, O. (2014) Treatment of influenza virus with beta-propiolactone alters viral membrane fusion. Biochim. Biophys. Acta Biomembr., 1839(1): 355-363. [Crossref] [PubMed]

13. Jagt, H.J.M., Bekkers, M.L.E., Bommel, S.A.J., Marel, P. and Schrier, C.C. (2010) The influence of the inactivating agent on the antigen content of inactivated Newcastle disease vaccines assessed by the in vitro potency test. Biologicals, 38(1): 128-134. [Crossref] [PubMed]

14. Berhane, Y., Berry, J.D., Ranadheera, C., Marszal, P., Nicolas, B., Yuan, X., Czub, M. and Weingartl H. (2006) Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus. J. Virol. Methods, 132(1-2): 59-68. [Crossref] [PubMed]

15. Delrue, I., Verzele, D., Madder, A. and Nauwynck, H.J. (2012) Inactivated virus vaccines from chemistry to prophylaxis: Merits, risks and challenges. Expert Rev. Vaccines, 11(6): 695-719. [Crossref] [PubMed]

16. Habib, M., Iftikhar, H., Hamid, I., Zong-zhao, Y., Jiang-bing, S. and Ning, C. (2006) Immunogenicity of formaldehyde and binary ethylenimine inactivated infectious bursal disease virus in broiler chicks. J. Zhejiang Univ. Sci. B, 7(8): 660-664. [Crossref] [PubMed] [PMC]

17. Sarkar, A., Selvan, R.P.T., Kishore, S., Ganesh, K. and Bhanuprakash, V. (2017) Comparison of different inactivation methods on the stability of Indian vaccine strains of foot and mouth disease virus. Biological, 48: 10-23. [Crossref] [PubMed]

18. Mondal, S.K., Neelima, M., Seetha, S., Rao, K.A. and Srinivasan, V.A. (2005) Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production. Biologicals, 33(3): 185-189. [Crossref] [PubMed]

19. Yang, D.K., Kim, H.H., Lee, K.W. and Song, J.Y. (2013) The present and future of rabies vaccine in animals. Clin. Exp. Vaccine Res., 2(1): 19-25. [Crossref] [PubMed] [PMC]

20. Astawa, I.N.M., Agustini, N.L.P., Tenaya, I.W.M. and Aryawiguna, I.P.G. (2018) Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells. J. Vet. Med .Sci., 80(10): 1596-1603. [Crossref] [PubMed] [PMC]

21. Yang, D.K., Kim, H.H., Nah, J.J., Lee, K.W. and Song, J.Y. (2012) Binary ethylenimine inactivated Japanese encephalitis virus antigen reveals hemagglutination. Open J. Vet. Med., 2(3): 120-123. [Crossref]

22. Astawa, N.M. and Adi, A.A.A. (2014) Immunological detection of Newcastle disease viral antigen in the naturally infected chickens by monoclonal antibodies against fusion-2 protein. J. Vet., 15(2): 158-165.

23. Kim, D., Huey, D., Oglesbee, M. and Niewiesk, S. (2011) Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies. Blood, 117(23): 6143-6151. [Crossref] [PubMed] [PMC]

24. Rauw, F., Gardin, Y., Palya, V., van Borm, S., Gonze, M., Lemaire, S., van den Berg, T. and Lambrecht, B. (2009) Humoral, cell-mediated and mucosal immunity induced by oculonasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines. Vaccine, 27(27): 3631-3642. [Crossref] [PubMed]

25. Lardinois, A., van den Berg, T., Lambrecht, B. and Steensels M. (2014) A model for the transfer of passive immunity against Newcastle disease and avian influenza in specific pathogen free chickens. Avian Pathol., 43(2): 118-124. [Crossref] [PubMed]

26. De Vriese, J., Steensels, M., Palya, V., Gardin, Y., Dorsey, K.M., Lambrecht, B., Van Borm, S. and van den Berg, T. (2010) Passive protection afforded by maternally-derived antibodies in chickens and the antibodies interference with the protection elicited by avian influenza-inactivated vaccines in progeny. Avian Dis., 54(s1): 246-252. [Crossref] [PubMed]

27. Abdi, R.D., Amsalu, K., Merera, O., Asfaw, Y., Gelaye, E., Yami, M. and Sori, T. (2016) Serological response and protection level evaluation in chickens exposed to grains coated with I2 Newcastle disease virus for effective oral vaccination of village chickens. BMC Vet. Res., 12(1): 150. [Crossref] [PubMed] [PMC]

28. Zhao, J., Yang, H., Xu, H., Ma, Z. and Zhang, G. (2017) Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza. Virol. J., 14(1): 56. [Crossref] [PubMed] [PMC]

29. Cornax, I., Diel, D.G., Rue, C.A., Estevez, C., Yu, Q., Miller, P.J. and Afonso, C.L. (2013) Newcastle disease virus fusion and haemagglutinin-neuraminidase proteins contribute to its macrophage host range. J. Gen. Virol., 94(Pt 6): 1189-1194. [Crossref] [PubMed] [PMC]

30. Miller, P.J. and Koch, G. (2013) Newcastle disease. In: Swayne, D.E., Glisson, J.R., McDougald, L.R., Nolan, L.K., Suarez, D.L. and Nair, V., editors. Diseases of Poultry. Wiley-Blackwell, Hoboken, New Jersey. p89-138.